CClinicalTrials.gg
CompletedNCT01416168Updated Nov 27, 2013

Pilot Study of a Geriatric Intervention After Colorectal and Lung Cancer Surgery

An interventional study of McCorkle Model Intervention in Colorectal Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute. Completed at 1 site in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2013-11-27.

Sponsored by H. Lee Moffitt Cancer Center and Research Institute · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

Surgery for colorectal cancer is a major surgery. People above the age of 60 tend to have a higher risk of complications. Some studies indicate that senior cancer patients might benefit from a home support after surgery by a geriatric nurse practitioner and a team, beside their usual post-operative care. The investigators team is planning a large study to assess whether this approach could help patients with colorectal cancer recover better from their surgery, get better cancer treatment after that (e.g. chemotherapy), and possibly live longer. This study you are asked to take part in is a pilot for this large study.

Read the detailed description

Our key background data come from the randomized study conducted by McCorkle et al.

After evaluation testing, patients will be randomly assigned (similarly to a coin toss) to one of two possible follow-up groups. One would be a regular post-surgery care group (control group), the other will have in addition a support by geriatric nurse practitioner (intervention group).

Patients who are assigned to the intervention group: once they arrive home, in addition to their normal post-surgery care, will receive a once a week home visit by a geriatric nurse practitioner (GNP). The GNP will also call the patient once a week in between. The GNP will check any problem patients may have during their recovery and provide or organize care for it. The GNP has a checklist of problems to address so that we can reliably reproduce our intervention in other patients. The GNP will work together with the patient's various doctors and caregivers, as well as a geriatric team. Some of the visits or the telephone calls maybe tape-recorded so that the research team can evaluate the information provided to the patient. We will record any complication patients might have from surgery.

No matter which treatment group the patient is assigned to, at the end of a 4 weeks period, we will repeat the tests we did at the beginning to see how they change.

02

Conditions studied

  • Colorectal Cancer

Keywords

  • Colon
  • Geriatric
  • McCorkle Model
  • Questionnaire
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's enrollment of 15 is below the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

H. Lee Moffitt Cancer Center and Research Institute is the lead sponsor of 533 studies on the registry; 74 are open to participants now.

Of its 99 completed or terminated interventional studies of FDA-regulated products, 57 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Colorectal cancer, stage III or IV, confirmed by histology
  • Abdominal surgery by a University of South Florida (USF) surgeon at Moffitt Cancer Center or Tampa General Hospital (TGH)
  • Age 60 years and older
  • Informed consent
  • Living within a one (1) hour radius of Moffitt

Exclusion criteria

Exclusion Criteria:

  • Discharge planned to a rehabilitation facility or a nursing home
  • Unable to answer the questionnaires (e.g. because of cognitive impairment, blindness, deafness)
  • Post-operative inpatient stay >one (1) month
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • No intervention
    Control Arm

    Usual post-surgical care

  • Experimental
    Intervention arm

    In addition to usual post-surgical care, the patients will receive a 4 week geriatric nurse practitioner-centered intervention, based on the McCorkle model.

    Other: McCorkle Model Intervention

Interventions

  • OtherMcCorkle Model Intervention

    The intervention will consist each week in a home visit and a phone call. The GNP conducting the home visit will identify current problems using a comprehensive geriatric assessment (CGA) and record problems on the Intervention and Recommendation Data Sheet. In addition, the cases will be reviewed at a weekly Intervention Team meeting between the intervention GNP (VM, CV), the geriatrician (VP), and the intervention PI (JO). That team meeting will also record how intervention goals for the various problems are met, using the instruments and criteria developed during our pilot study5. To ensure optimal consistency and an up-to-date evidence-based approach over the 4 years of the intervention, treatment recommendations will be offered according to national evidence-based treatment guidelines.

06

What researchers measure

Primary outcomes

  1. Feasibility of the Intervention

    The primary end-point for the pilot will be the feasibility of the intervention, measured as follows: * A compliance of \>=90% with the intervention table on page 17 * A success rate (improvement or resolution of problems) of \>= 80% * A completion rate of \>=90% of the initial and final study questionnaires

    Time frame: 30 days per participant

Secondary outcomes

  1. Whether the Intervention is Faithful to Dr. McCorkle's Original Intervention

    Aim 2 will be judged qualitatively. Dr. Ruth McCorkle and Dr. Janine Overcash will judge whether the intervention is faithful enough to Dr McCorkle's original intervention and whether it can be carried effectively by the trained personnel.

    Time frame: 30 days per participant

  2. A Successful Collection and Testing of >=90% of the Samples Tested

    Aim 3 will be judged by assessing the percentage of tests that could or not be performed on the Moffitt patients.

    Time frame: 30 days per participant

  3. Effect Size Estimates for Within-group Changes Between Baseline and 1-month

    Aim 4 will be assessed by the activities of daily living (ADL), instrumental activities of daily living (IADL), complications and FACT-colorectal (FACT-C) v.4 questionnaires at baseline and end of intervention.

    Time frame: 30 days per participant

07

Study locations

1 site
  • H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 27, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01416168
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Tampa General Hospital, University of South Florida, Yale University
Responsible party
Sponsor
First posted
Aug 12, 2011
Start date
Dec 2008
Primary completion
Apr 2013
Completion
Nov 2013
Last update
Nov 27, 2013

Study contacts

Martine Extermann, M.D., Ph.D.
principal investigator · H. Lee Moffitt Cancer Center and Research Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion